Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
XENE	XENON PHARMACEUTICALS INC	$2.46B	-32.40%	-30.80%	-35.93%	-38.00%	0.06	17.66	100.00%	-3,352.60%	-3,406.93%
REVB	REVELATION BIOSCIENCES INC	$790.31k	-505.40%	-194.70%	-500.15%	330.90%	0.38	3.61	N/A	N/A	N/A
RZLT	REZOLUTE INC	$378.00M	-70.10%	-63.10%	-86.68%	-89.10%	0.15	8.43	N/A	N/A	N/A
MGRM	MONOGRAM TECHNOLOGIES INC	$102.07M	-129.20%	-103.60%	-119.66%	-3,401.50%	0.31	7.00	N/A	N/A	N/A
ATOS	ATOSSA THERAPEUTICS INC	$106.44M	-36.30%	-33.70%	-40.33%	36,336.60%	0.08	12.67	N/A	N/A	N/A
IPA	IMMUNOPRECISE ANTIBODIES LTD	$35.81M	-148.10%	-82.10%	-139.08%	-174.50%	0.81	2.32	50.80%	-192.20%	-212.12%
VIR	VIR BIOTECHNOLOGY INC	$706.40M	-47.50%	-39.30%	-49.47%	-52.60%	0.25	6.79	96.20%	-2,769.00%	-2,775.77%
CNSP	CNS PHARMACEUTICALS INC	$4.65M	-385.40%	-193.20%	-142.19%	563.30%	0.25	4.94	N/A	N/A	N/A
NUVB	NUVATION BIO INC	$660.11M	-147.60%	-110.30%	-137.81%	-130.20%	0.17	9.01	16.30%	-5,534.20%	-5,530.60%
PDSB	PDS BIOTECHNOLOGY CORP	$55.77M	-150.60%	-69.10%	-122.83%	-385.60%	1.10	2.33	N/A	N/A	N/A
CRDL	CARDIOL THERAPEUTICS INC	$109.04M	-210.20%	-141.50%	-202.13%	580.00%	0.45	3.26	N/A	N/A	N/A
IBIO	IBIO INC	$12.39M	-130.50%	-89.30%	-151.50%	-244.90%	0.68	1.12	100.00%	-5,597.90%	-5,537.07%
BBNX	BETA BIONICS INC	$604.39M	N/A	N/A	N/A	N/A	0.08	15.88	N/A	N/A	N/A
DOMH	DOMINARI HOLDINGS INC	$77.32M	-102.50%	-87.00%	-90.20%	-99.10%	0.23	5.74	100.00%	-167.70%	-167.73%
ACRV	ACRIVON THERAPEUTICS INC	$38.57M	-44.70%	-40.90%	-51.44%	-55.20%	0.10	11.17	N/A	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$571.39M	-106.30%	-87.90%	-108.80%	-160.80%	0.09	12.05	746.80%	17,205.70%	17,255.66%
TYRA	TYRA BIOSCIENCES INC	$516.89M	-27.50%	-26.10%	-29.29%	-36.60%	0.06	22.78	N/A	N/A	N/A
BMGL	BASEL MEDICAL GROUP LTD	$29.71M	N/A	N/A	N/A	N/A	1.06	N/A	N/A	N/A	N/A
EYPT	EYEPOINT PHARMACEUTICALS INC	$657.15M	-54.30%	-41.80%	-45.71%	-62.60%	0.22	7.85	93.30%	-261.90%	-261.73%
RANI	RANI THERAPEUTICS HOLDINGS INC	$29.52M	-2,437.00%	-80.50%	-628.76%	-58.10%	-9.65	0.88	100.00%	-2,483.20%	-2,093.25%
SXTP	60 DEGREES PHARMACEUTICALS INC	$3.49M	-249.60%	-183.00%	-245.38%	-560.50%	0.47	3.14	42.60%	-1,495.80%	-1,426.44%
APGE	APOGEE THERAPEUTICS INC	$2.63B	-28.30%	-27.00%	-30.14%	-35.80%	0.06	15.82	N/A	N/A	N/A
ESPR	ESPERION THERAPEUTICS INC	$198.20M	N/A	-45.90%	-166.90%	-16.20%	-1.76	1.18	65.30%	-59.00%	-34.12%
INZY	INOZYME PHARMA INC	$258.25M	-160.00%	-82.50%	-192.96%	-79.90%	1.99	2.19	N/A	N/A	N/A
QNCX	QUINCE THERAPEUTICS INC	$69.11M	-172.70%	-50.30%	-61.38%	-101.70%	4.76	4.05	N/A	N/A	N/A
PROF	PROFOUND MEDICAL CORP	$183.38M	-80.90%	-65.70%	-66.88%	-254.80%	0.20	11.32	66.60%	-322.20%	-326.28%
VVOS	VIVOS THERAPEUTICS INC	$22.79M	-170.40%	-77.80%	-170.75%	-566.70%	1.56	0.77	58.70%	-76.80%	-76.82%
IOBT	IO BIOTECH INC	$90.92M	-162.60%	-125.10%	-354.39%	1,698.90%	0.73	2.32	N/A	N/A	N/A
RAPT	RAPT THERAPEUTICS INC	$121.21M	-81.50%	-70.20%	-65.13%	-157.70%	0.06	21.11	N/A	N/A	N/A
DNA	GINKGO BIOWORKS HOLDINGS INC	$664.92M	-63.10%	-32.70%	-40.11%	-41.90%	1.00	4.88	80.00%	-198.80%	-198.98%
GLPG	GALAPAGOS NV	$1.84B	N/A	N/A	N/A	N/A	0.46	7.95	N/A	N/A	N/A
OPK	OPKO HEALTH INC	$1.05B	-2.80%	-1.80%	2.98%	6.20%	0.62	2.49	31.80%	-5.70%	7.93%
CRNX	CRINETICS PHARMACEUTICALS INC	$2.66B	-30.90%	-28.10%	-25.17%	-35.80%	0.09	22.53	100.00%	-43,191.10%	-43,191.05%
APDN	APPLIED DNA SCIENCES INC	$1.98M	-412.90%	-315.90%	-66.06%	-629.00%	0.27	4.45	40.80%	-1,218.50%	-194.18%
RVMD	REVOLUTION MEDICINES INC	$6.87B	-37.10%	-32.80%	-31.64%	-41.40%	0.14	13.46	N/A	N/A	N/A
ACET	ADICET BIO INC	$50.54M	-59.10%	-50.70%	-67.11%	-93.10%	0.19	9.34	N/A	N/A	N/A
ONCO	ONCONETIX INC	$2.45M	-2,162.10%	-136.60%	-1,178.61%	1,019.50%	3.57	0.17	47.40%	-2,986.30%	-2,899.46%
NUVL	NUVALENT INC	$5.60B	-31.30%	-29.30%	-29.14%	-37.80%	0.09	14.48	N/A	N/A	N/A
AVTX	AVALO THERAPEUTICS INC	$52.41M	111.00%	58.90%	52.60%	-185.60%	0.13	22.61	164.40%	16,556.00%	15,852.15%
SRRK	SCHOLAR ROCK HOLDING CORP	$3.21B	-118.20%	-82.00%	-71.40%	-117.50%	0.31	10.25	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$216.50M	-53.60%	-22.20%	-24.81%	-756.50%	0.92	4.10	100.00%	-153.80%	-149.12%
ENGN	ENGENE HOLDINGS INC	$185.00M	-32.60%	-28.30%	-30.82%	-49.30%	0.17	12.67	N/A	N/A	N/A
JANX	JANUX THERAPEUTICS INC	$1.37B	-9.30%	-8.90%	-7.52%	-10.40%	0.04	58.47	100.00%	-832.70%	-832.71%
NAOV	NANOVIBRONIX INC	$2.46M	-54.70%	-38.60%	-15.13%	-1,215.00%	0.24	0.47	45.60%	-210.80%	-204.02%
CVM	CEL SCI CORP	$7.19M	-268.40%	-110.70%	-162.85%	-105.00%	1.73	0.55	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$356.77M	-42.50%	-38.30%	-47.38%	-52.80%	0.19	8.33	100.00%	-6,496.80%	-6,496.82%
ELDN	ELEDON PHARMACEUTICALS INC	$167.07M	-51.60%	-27.00%	-25.16%	-32.20%	0.41	13.91	N/A	N/A	N/A
NAUT	NAUTILUS BIOTECHNOLOGY INC	$92.09M	-31.90%	-27.40%	-31.28%	-27.40%	0.17	17.36	N/A	N/A	N/A
MRNA	MODERNA INC	$11.10B	-30.10%	-23.00%	-30.68%	-29.50%	0.26	4.22	54.10%	-105.70%	-107.21%
ALT	ALTIMMUNE INC	$343.08M	-65.40%	-58.40%	-61.65%	-91.20%	0.11	15.85	100.00%	-601,600.00%	-606,080.00%
VTYX	VENTYX BIOSCIENCES INC	$146.95M	-47.40%	-43.50%	-51.43%	-51.30%	0.09	19.57	N/A	N/A	N/A
STAA	STAAR SURGICAL CO	$842.93M	-17.90%	-14.10%	-15.76%	-20.20%	0.31	4.78	74.00%	-25.50%	-21.97%
ALEC	ALECTOR INC	$141.99M	-100.60%	-25.10%	-41.31%	-34.50%	3.32	3.34	100.00%	-139.70%	-139.60%
OTLK	OUTLOOK THERAPEUTICS INC	$53.04M	-35.30%	75.40%	-367.87%	414.00%	-1.59	0.72	N/A	N/A	N/A
IMTX	IMMATICS NV	$673.39M	-4.60%	-3.40%	-3.04%	-5.20%	0.20	10.28	100.00%	-15.00%	-12.34%
MAZE	MAZE THERAPEUTICS INC	$510.67M	N/A	N/A	N/A	N/A	0.14	16.10	N/A	N/A	N/A
TRML	TOURMALINE BIO INC	$406.65M	-26.70%	-26.10%	-29.61%	-31.00%	0.03	33.87	N/A	N/A	N/A
OABI	OMNIAB INC	$212.86M	-21.40%	-18.80%	-23.12%	-77.80%	0.12	4.70	100.00%	-229.10%	-254.78%
TARA	PROTARA THERAPEUTICS INC	$108.03M	-36.40%	-33.30%	-28.11%	-133.30%	0.06	18.03	N/A	N/A	N/A
AURA	AURA BIOSCIENCES INC	$314.68M	-58.60%	-49.70%	-66.05%	-57.50%	0.21	11.06	N/A	N/A	N/A
SVRA	SAVARA INC	$354.32M	-65.90%	-52.40%	-57.59%	-53.80%	0.28	14.91	N/A	N/A	N/A
TIL	INSTIL BIO INC	$143.86M	-45.50%	-29.20%	-30.37%	-21.00%	0.64	30.33	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$1.99B	50.30%	46.10%	47.25%	54.50%	0.06	18.50	87.50%	1,798.30%	1,917.72%
QURE	UNIQURE NV	$765.93M	-483.90%	-34.30%	-26.81%	-19.90%	16.97	11.99	54.00%	-1,077.10%	-755.18%
RPTX	REPARE THERAPEUTICS INC	$60.91M	-78.10%	-67.10%	-101.29%	-151.70%	0.15	7.42	100.00%	-11,919.30%	-11,809.23%
DCGO	DOCGO INC	$150.64M	-0.20%	-0.10%	2.13%	3.30%	0.42	2.44	34.00%	-0.10%	1.32%
ROIV	ROIVANT SCIENCES LTD	$7.44B	-3.40%	-2.90%	-2.34%	-4.50%	0.05	33.47	96.90%	-592.00%	-426.14%
XBIT	XBIOTECH INC	$96.65M	-21.10%	-19.60%	-22.07%	-188.30%	0.04	29.15	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$758.94M	-101.60%	-58.40%	-58.28%	-60.20%	1.98	5.80	96.10%	-757.50%	-727.96%
APLS	APELLIS PHARMACEUTICALS INC	$2.25B	-100.10%	-25.60%	-28.28%	-22.80%	3.92	4.08	83.00%	-28.80%	-22.93%
GCTK	GLUCOTRACK INC	$3.01M	N/A	-624.40%	-338.46%	1,543.40%	0.32	4.85	N/A	N/A	N/A
CRGX	CARGO THERAPEUTICS INC	$193.21M	-58.40%	-50.40%	-69.65%	-63.80%	0.28	6.30	N/A	N/A	N/A
KTTA	PASITHEA THERAPEUTICS CORP	$5.47M	-88.10%	-81.20%	-104.16%	3,238.60%	0.13	3.84	N/A	N/A	N/A
ETNB	89BIO INC	$1.42B	-81.40%	-70.20%	-58.76%	-105.30%	0.13	18.03	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$57.43M	-347.60%	-59.50%	-116.00%	-133.70%	-13.45	2.16	100.00%	-369.10%	-328.94%
PCVX	VAXCYTE INC	$4.25B	-17.10%	-16.30%	-15.53%	-20.40%	0.06	17.70	N/A	N/A	N/A
FEMY	FEMASYS INC	$25.52M	-392.40%	-137.10%	-564.70%	-201.20%	5.65	0.93	66.20%	-1,242.60%	-1,142.11%
MNMD	MIND MEDICINE (MINDMED) INC	$504.70M	-33.40%	-26.60%	-30.70%	-216.80%	0.24	7.27	N/A	N/A	N/A
CATX	PERSPECTIVE THERAPEUTICS INC	$243.47M	-27.40%	-23.50%	-27.51%	-62.10%	0.16	17.02	100.00%	-5,790.10%	-5,922.64%
CRVO	CERVOMED INC	$51.61M	-44.10%	-40.60%	-53.91%	-56.50%	0.11	9.78	100.00%	-200.60%	-200.58%
MURA	MURAL ONCOLOGY PLC	$43.17M	-83.40%	-70.70%	-120.02%	-244.80%	0.22	5.08	N/A	N/A	N/A
NNVC	NANOVIRICIDES INC	$22.50M	-95.40%	-84.30%	-110.12%	-160.10%	0.14	2.28	N/A	N/A	N/A
QTRX	QUANTERIX CORP	$259.77M	-14.50%	-11.80%	-14.19%	-14.80%	0.25	8.29	59.70%	-35.30%	-37.24%
INAB	IN8BIO INC	$6.26M	-217.00%	-138.40%	-162.16%	-227.20%	0.43	4.30	N/A	N/A	N/A
PLSE	PULSE BIOSCIENCES INC	$998.34M	-71.00%	-60.30%	-47.96%	-543.20%	0.13	15.58	N/A	N/A	N/A
NEOG	NEOGEN CORP	$1.10B	-16.70%	-11.30%	-11.17%	-28.70%	0.52	3.91	48.80%	-53.60%	-48.03%
MDCX	MEDICUS PHARMA LTD	$39.81M	-380.10%	-224.20%	-624.51%	1,314.70%	1.64	1.53	N/A	N/A	N/A
RCKT	ROCKET PHARMACEUTICALS INC	$279.04M	-64.90%	-56.10%	-58.78%	-85.00%	0.14	9.19	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$1.76B	-44.20%	-31.00%	-29.22%	-42.80%	0.31	8.81	100.00%	-609.20%	-609.18%
CYBN	CYBIN INC	$194.41M	-44.70%	-42.70%	-47.70%	-769.80%	0.09	7.75	N/A	N/A	N/A
CGC	CANOPY GROWTH CORP	$209.27M	-112.80%	-52.00%	-71.78%	-51.70%	0.88	3.12	29.60%	-222.40%	-219.70%
NNOX	NANO-X IMAGING LTD	$326.14M	-30.90%	-27.70%	-29.83%	-68.30%	0.11	5.30	-100.50%	-472.20%	-475.22%
SGMT	SAGIMET BIOSCIENCES INC	$258.53M	-35.20%	-34.10%	-41.09%	-68.10%	0.05	20.34	N/A	N/A	N/A
THRD	THIRD HARMONIC BIO INC	$244.14M	-19.30%	-18.70%	-19.45%	-952.20%	0.03	54.10	N/A	N/A	N/A
ACLX	ARCELLX INC	$3.56B	-35.30%	-22.70%	-36.07%	-35.20%	0.56	4.93	100.00%	-211.50%	-251.56%
LAB	STANDARD BIOTOOLS INC	$489.97M	-27.60%	-20.60%	-24.68%	-46.00%	0.28	6.12	47.00%	-78.20%	-76.11%
SYRE	SPYRE THERAPEUTICS INC	$934.88M	-49.10%	-41.10%	-41.86%	-53.00%	0.18	8.06	N/A	N/A	N/A
CSTL	CASTLE BIOSCIENCES INC	$587.26M	-1.20%	-1.00%	-0.35%	-0.60%	0.14	9.37	81.90%	-1.50%	-0.47%
DMAC	DIAMEDICA THERAPEUTICS INC	$153.09M	-61.30%	-55.50%	-78.86%	-69.80%	0.14	8.02	N/A	N/A	N/A
KYTX	KYVERNA THERAPEUTICS INC	$119.72M	-51.60%	-45.90%	-63.90%	-73.70%	0.16	7.44	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	651	+0.06%	-1.70%	+1.60%	-72.42%	-123.20x	4.46x	-75.05%	-3.00%	+5.27%	+105.42%	Strong Buy
Diagnostics & Research	57	+1.65%	+1.97%	+6.85%	-16.17%	20.68x	3.62x	-11.08%	+5.97%	+10.65%	+13.03%	Buy
Drug Manufacturers - General	18	+1.49%	+1.81%	+2.52%	-11.78%	37.96x	6.00x	+50.67%	+9.83%	+16.77%	+52.93%	Buy
Drug Manufacturers - Specialty & Generic	77	+0.39%	-2.10%	-1.07%	-59.60%	-16.19x	2.24x	+10.00%	+4.88%	+10.96%	+40.31%	Buy
Healthcare Plans	11	+2.49%	+5.19%	+6.05%	-17.90%	14.78x	2.12x	+16.83%	+5.31%	+12.34%	+19.15%	Buy
Health Information Services	56	-0.74%	+2.56%	+0.73%	-62.63%	44.43x	4.02x	+8.19%	+4.28%	+9.34%	+18.52%	Buy
Medical Care Facilities	48	+0.35%	-1.58%	-1.72%	-8.61%	16.79x	4.71x	-73.73%	+6.80%	+14.34%	+20.45%	Buy
Medical Devices	139	-0.25%	+0.23%	-1.14%	-20.38%	36.47x	4.12x	+7.98%	+8.31%	+8.92%	+29.79%	Strong Buy
Medical Distribution	10	-0.87%	+0.99%	+2.22%	+27.49%	28.85x	1,391.11x	-0.96%	+3.60%	+22.84%	+4.10%	Buy
Medical Instruments & Supplies	56	+0.86%	+1.82%	+2.81%	-59.63%	41.14x	3.72x	+10.21%	+8.42%	+10.90%	+24.09%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 47, which is 21 points higher than the healthcare sector average of 26. It passed 17 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 56.22% over the past year, overperforming other healthcare stocks by 108 percentage points.

Phibro Animal Health has an average 1 year price target of $24.00, a downside of -9.84% from Phibro Animal Health's current stock price of $26.62.

Phibro Animal Health stock has a consensus Sell recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 0% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.

2. Enhabit (NYSE:EHAB)

Enhabit (NYSE:EHAB) is the #2 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Enhabit (NYSE:EHAB) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: A, Financials: B, and AI: C.

Enhabit (NYSE:EHAB) has a Due Diligence Score of 7, which is -19 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates EHAB as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Enhabit has seen its stock lose -9.94% over the past year, overperforming other healthcare stocks by 42 percentage points.

3. Trubridge (NASDAQ:TBRG)

Trubridge (NASDAQ:TBRG) is the #3 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Trubridge (NASDAQ:TBRG) is: Value: C, Growth: A, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.

Trubridge (NASDAQ:TBRG) has a Due Diligence Score of 14, which is -12 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates TBRG as a "A".It passed 5 out of 38 due diligence checks and has weak fundamentals. Trubridge has seen its stock return 122.14% over the past year, overperforming other healthcare stocks by 174 percentage points.

Trubridge has an average 1 year price target of $28.50, an upside of 21.38% from Trubridge's current stock price of $23.48.

Trubridge stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Trubridge, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 12.47%, which is 11 percentage points higher than the healthcare sector average of 1.94%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 32.4% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 7.89%, which is 6 percentage points higher than the healthcare sector average of 1.94%.

Cryo Cell International's dividend payout ratio of 5,000% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 6.91%, which is 5 percentage points higher than the healthcare sector average of 1.94%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 160.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.52% in the last day, and up 0.35% over the last week. Mustang Bio was the among the top gainers in the healthcare sector, gaining 114.66% yesterday.

Mustang Bio shares are trading higher after the company announced it received FDA Orphan Drug designation status for MB-101.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 5.29% in the past year. It has overperformed other stocks in the healthcare sector by 57 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 9.45% in the past year. It has overperformed other stocks in the healthcare sector by 62 percentage points.

3. Biote (NASDAQ:BTMD)

Biote (NASDAQ:BTMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Biote has a valuation score of 29, which is 13 points higher than the healthcare sector average of 16. It passed 2 out of 7 valuation due diligence checks.

Biote's stock has dropped -44.32% in the past year. It has overperformed other stocks in the healthcare sector by 8 percentage points.

Are healthcare stocks a good buy now?

51.08% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 47.13% over the next year.

4.8% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.51% of healthcare stocks are rated B (Buy), 44.72% are rated C (Hold), 25.78% are rated D (Sell), and 13.19% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.55x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Enhabit (NYSE:EHAB)

3. Trubridge (NASDAQ:TBRG)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Biote (NASDAQ:BTMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Enhabit (NYSE:EHAB)

3. Trubridge (NASDAQ:TBRG)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Biote (NASDAQ:BTMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.